711 related articles for article (PubMed ID: 16355335)
21. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.
Williams DL; Pittman TL; Gillis TP; Matsuoka M; Kashiwabara Y
J Clin Microbiol; 2001 Jun; 39(6):2083-8. PubMed ID: 11376039
[TBL] [Abstract][Full Text] [Related]
23. Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.
Williams DL; Spring L; Harris E; Roche P; Gillis TP
Antimicrob Agents Chemother; 2000 Jun; 44(6):1530-7. PubMed ID: 10817704
[TBL] [Abstract][Full Text] [Related]
24. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
Waters MF; Pearson JM; Rees RJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
[No Abstract] [Full Text] [Related]
25. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
26. A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampin.
Zhang L; Namisato M; Matsuoka M
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):468-72. PubMed ID: 15755201
[TBL] [Abstract][Full Text] [Related]
27. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
28. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
29. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
30. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
31. Active surveillance of leprosy contacts in country with low prevalence rate.
Kai M; Maeda Y; Maeda S; Fukutomi Y; Kobayashi K; Kashiwabara Y; Makino M; Abbasi MA; Khan MZ; Shah PA
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):50-3. PubMed ID: 15217314
[TBL] [Abstract][Full Text] [Related]
32. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
33. Drug-resistant leprosy: monitoring and current status.
Williams DL; Gillis TP
Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
[No Abstract] [Full Text] [Related]
34. Primary and secondary dapsone resistance of M. leprae in Martinique, Guadeloupe, New Caledonia, Tahiti, Senegal, and Paris between 1980 and 1985.
Guelpa-Lauras CC; Cartel JL; Constant-Desportes M; Millan J; Bobin P; Guidi C; Brucker G; Flageul B; Guillaume JC; Pichet C
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):672-9. PubMed ID: 3323369
[TBL] [Abstract][Full Text] [Related]
35. Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
Li X; Li G; Yang J; Jin G; Shao Y; Li Y; Wei P; Zhang L
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293307
[TBL] [Abstract][Full Text] [Related]
36. Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches.
Li W; Sakamuri RM; Lyons DE; Orcullo FM; Shinde V; Dela Pena EL; Maghanoy AA; Mallari IB; Tan EV; Nath I; Brennan PJ; Balagon M; Vissa V
Antimicrob Agents Chemother; 2011 Nov; 55(11):5384-7. PubMed ID: 21859943
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
[TBL] [Abstract][Full Text] [Related]
38. Primary dapsone resistant Mycobacterium leprae in a non endemic country.
Jamil A; Noor NM; Osman AS; Baseri MM; Muthupalaniappen L
Indian J Dermatol Venereol Leprol; 2013; 79(4):527-9. PubMed ID: 23760326
[No Abstract] [Full Text] [Related]
39. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
40. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
